Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

Published:2015-10 Issue:7 Volume:44 Page:1141-1147
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Bachet Jean-Baptiste,Gay Fabien,Maréchal Raphaël,Galais Marie-Pierre,Adenis Antoine,MsC David Salako,,Cros Jerome,Demetter Pieter,Svrcek Magali,Bardier-Dupas Armelle,Emile Jean-François,Hammel Pascal,Ebenezer Christelle,Berlier Willy,Godfrin Yann,André Thierry

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.;Richards;Leukemia,1998

2. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia.;Jones;Med Pediatr Oncol,1977

3. How I treat older patients with ALL.;Gokbuget;Blood,2013

4. L-Asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.;Domenech;Br J Haematol,2011

5. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.;Lorenzi;Mol Cancer Ther,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications;Advanced Biology;2024-07-22

2. Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma;Cancer & Metabolism;2024-06-30

3. Exploiting pancreatic cancer metabolism: challenges and opportunities;Trends in Molecular Medicine;2024-06

4. Artificial cells for in vivo biomedical applications through red blood cell biomimicry;Nature Communications;2024-03-20

5. Erythrocyte-based Drug Delivery: How Far from Clinical Application?;Current Drug Delivery;2024-01